Stability of daptomycin reconstituted vials and infusion solutions

scientific article published on 14 March 2016

Stability of daptomycin reconstituted vials and infusion solutions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/EJHPHARM-2015-000784
P932PMC publication ID6452341
P698PubMed publication ID31156998

P50authorRocío Vázquez SánchezQ88617124
P2093author name stringJavier Sánchez-Rubio Ferrández
Teresa Molina García
María Carmen Lozano Estevan
Damián Córdoba Díaz
Manuel Córdoba Díaz
P2860cites workDaptomycin use in patients with cancer and neutropenia: data from a retrospective registry.Q33588510
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusQ34558111
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureusQ35166213
Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureusQ36903680
Daptomycin: a review 4 years after first approvalQ36972980
Guidelines for the practical stability studies of anticancer drugs: a European consensus conferenceQ37917214
Outpatient parenteral antibiotic therapy: principles and practiceQ38100428
Effect of glucose concentration on the stability of daptomycin in peritoneal solutionsQ42083443
Physical and chemical compatibility of daptomycin with nine medicationsQ45029806
An HPLC assay for daptomycin in serumQ46340635
Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer's injection and stored in polypropylene syringes at 4 and -20°C.Q53551063
Daptomycin compatibility in peritoneal dialysis solutionsQ84615314
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)107-110
P577publication date2016-03-14
P1433published inEuropean journal of hospital pharmacyQ20181626
P1476titleStability of daptomycin reconstituted vials and infusion solutions
P478volume25

Search more.